Thursday, September 14, 2023 9:47:51 AM
Recent AVTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 12:07:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 09:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2025 12:04:39 PM
- Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer • GlobeNewswire Inc. • 01/02/2025 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/31/2024 09:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2024 12:03:53 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 05:05:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 12:30:28 PM
- Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants • GlobeNewswire Inc. • 11/12/2024 12:00:00 PM
- Avalo Therapeutics to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 11/11/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/07/2024 10:00:07 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/07/2024 12:20:12 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/07/2024 12:17:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 12:04:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 12:02:05 PM
- Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates • GlobeNewswire Inc. • 11/07/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 11:13:49 AM
- Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa • GlobeNewswire Inc. • 10/08/2024 11:00:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/08/2024 12:06:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 11:22:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 11:01:31 AM
- Avalo Announces Participation in September Investor Conferences • GlobeNewswire Inc. • 09/04/2024 11:00:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/23/2024 08:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:04:51 PM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM